Back to search

West Virginia University

Dielectrophoretic Biomarkers for Cancer Detection and Cell Analysis: Integrating Microfluidics and AI

Abstract

dc:description.abstract

Pancreatic ductal adenocarcinoma (PDAC) carries a five-year survival rate of 13%, driven largely by late-stage diagnosis and the absence of sensitive noninvasive screening tools. Current diagnostic methods lack the sensitivity to detect disease-associated systemic changes at early and precancerous stages, representing a critical clinical gap. This dissertation addresses the central hypothesis that PDAC and its pathological subtypes induce measurable, disease-associated electrophysiological changes in circulating PBMCs that can serve as correlative liquid-biopsy biomarkers. To test this hypothesis, this work asks: can dielectrophoresis (DEP), impedance and zeta potential analysis with AI-assisted classification distinguish benign pancreatic conditions (non-malignant control), precancerous lesions (primarily IPMNs), PDAC, and other pancreatic and periampullary pathologies through label-free electrophysiological profiling of PBMCs? The work advances through four aims: electrical signature identification; immune subpopulation analysis via flow-sorted PBMC subsets and flow cytometry; correlative validation using zeta potential and impedance-based characterization; and AI-based multiparameter classification, including bulk PBMC analysis and PBMC subpopulations (T cells, Monocytes, Neutrophils, and Others). Using a DEPtech 3DEP analyzer and single-shell biophysical modeling, seven dielectric parameters were quantified per group. Pairwise Welch’s t-tests identified statistically significant differences (p < 0.05), across the four groups – benign, precancerous, PDAC, and others, with no single parameter separating all four; membrane capacitance (Cmem), membrane conductivity (σmem), and crossover frequencies (fx01, fx02) emerged as the most consistently discriminating feature combination (AUC up to 0.969). PDAC-associated PBMCs showed a reduced fₓ₀₁ (≈ 203 kHz) relative to precancerous (≈ 342 kHz) and benign groups (≈ 155 kHz), with Clausius–Mossotti modeling revealing elevated peak polarization in PDAC. Complementary impedance analysis–including phase, Nyquist, imaginary impedance, and Cole–Cole permittivity plots, demonstrated distinct frequency-dependent electrical profiles across disease states, with benign PBMCs showing the most divergent impedance behavior. Among supervised machine learning classifiers, Random Forest demonstrated the strongest and most stable performance (AUC ≈0.967, CV accuracy ≈0.832), outperforming linear and kernel-based models across all four disease groups. Correlative validation integrated zeta potential characterization of sorted PBMC subpopulations. Resulting data from healthy PBMCs show distinct electrokinetic baseline profiles across subpopulations − monocytes (−25.4 mV), T-cells (−26.6 mV), Neutrophils (-23.9 mV), and other subsets (−17.9 mV). Under PDAC, the changes were subset-specific rather than uniform: monocytes became less negative (−8.6 mV), the most pronounced shift in the dataset, while other subsets varied. This identified monocytes as the most electrically distinct subset, with zeta potential and model-derived impedance converging on the monocyte phenotype as correlative, not mechanistic, support. RNA profiling and mechanistic validation are considered future directions for work. Collectively, this work supports DEP-based immunophenotyping of PBMCs as a rapid, noninvasive adjunct for pancreatic disease evaluation, with future refinement through subpopulation-specific ML model training and clinical validation.

Degree

thesis:*
Name thesis:degree_name
PhD
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemical and Biomedical Engineering

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Oladokun, Raphael Olumide
Contributors dc:contributor
  • Soumya Srivastava
  • Srinivas Palanki
  • Timothy Eubank
  • Donald Adjeroh
  • Loren Rieth

Subjects

dc:subject × 14

Identifiers

dc:identifier.*
Identifier
<p><a href="https://orcid.org/0009-0005-3073-6777">https://orcid.org/0009-0005-3073-6777</a></p>
https://researchrepository.wvu.edu/etd/13489

Chain of custody

source
Harvested from
West Virginia University
Base URL
researchrepository.wvu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Oladokun, Raphael Olumide. Dielectrophoretic Biomarkers for Cancer Detection and Cell Analysis: Integrating Microfluidics and AI. Dissertation thesis, https://doi.org/10.33915/etd.13489